Serology test | Range of test | Median (IQR) | Total | DM+ | CVD+ | Frail+ |
---|---|---|---|---|---|---|
(U/ml) | Titer (U/ml) | number(%) | (n = 59) | (n = 143) | (n = 131) | |
HSV a IgG positive | 30-2000 | 437 (389–484) | 275 (93%) | 57 (97%) | 133 (93%) | 122 (93%) |
HSV a IgG negative | - | 20 (7%) | 2 (3%) | 10 (7%) | 9 (7%) | |
VZV a IgG positive | 100-2000 | 994 (612–1403) | 292 (99%) | 59 (100%) | 141 (99%) | 128 (98%) |
VZV a IgG negative | - | 3 (1%) | 0 (0%) | 2 (1%) | 3 (2%) | |
EBV a IgG positive | 11-200 | 200 (130–200) | 291 (99)% | 58 (98%) | 141 (99%) | 128 (98%) |
EBV a IgG negative | - | 4 (1%) | 1 (2%) | 2 (1%) | 3 (2%) | |
CMV a IgG positive | 226 (77%) | 46 (78%) | 115 (80%) | 108 (82%)b | ||
• AxSYM | 15-250 | 250 (192–250) | ||||
• DSXTM | 40-2000 | 373 (290–463) | ||||
CMV a IgG negative | - | 69 (23%) | 13 (22%) | 28 (20%) | 23 (18%)b | |
HHV6 a IgG positive | >1.1 | 1.67 (1.37-2.34) | 193 (65%) | 45 (76%)c | 97 (68%) | 90 (69%) |
HHV6 a IgG negative | - | 102 (35%) | 14 (24%)c | 46 (32%) | 41 (31%) | |
CP a IgG positive | 45-270 | 81 (59–116) | 150 (51%) | 28 (47%) | 74 (52%) | 68 (52%) |
CP a IgG negative | - | 144 (49%) | 31 (53%) | 69 (48%) | 63 (48%) | |
HP a IgG positive | 20-650 | 97 (36–211) | 173 (59%) | 32 (54%) | 82 (47%) | 77 (59%) |
HP a IgG negative | - | 121 (41%) | 27 (46%) | 61 (43%) | 54 (41%) | |
Pathogen burden d | - | |||||
● Pathogen burden ≤ 4 | 53 (18%) | 9 (15%) | 25 (18%) | 18 (14%) | ||
● Pathogen burden = 5 | - | 95 (32%) | 18 (31%) | 46 (32%) | 44 (33%) | |
● Pathogen burden = 6 | - | 103 (35%) | 23 (39%) | 46 (32%) | 48 (37%) | |
● Pathogen burden = 7 | - | 44 (15%) | 9 (15%) | 26 (18%) | 21 (16%) |